Pro Medicus is a health information services business based in Australia. Pro Medicus shares (PME) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Pro Medicus has a trailing 12-month revenue of around $161.5 million. If you're looking to buy shares, check out the steps below.
To buy shares listed in Australia such as Pro Medicus, you'll need to sign up to a broker with access to the ASX. Our table can help you compare share trading platforms and choose or you can see our list of the best share trading platforms in Australia. Then follow these steps.
Our top pick for
Best for day trading
Our top pick for
Education & learning
Our top pick for
Low commission
| 52-week range | $70.5453 - $151.84 |
|---|---|
| 50-day moving average | $138.2406 |
| 200-day moving average | $112.8195 |
| Target price | $111.66 |
| PE ratio | 193.2051 |
| Dividend yield | $0.4 (0.29%) |
| Earnings per share (TTM) | $0.78 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the last close of A$152.11
| 1 week (2024-08-27) | 2.90% |
|---|---|
| 1 month (2024-08-02) | 7.81% |
| 3 months (2024-06-04) | 29.48% |
| 6 months (2024-03-04) | 52.55% |
| 1 year (2023-09-04) | 108.94% |
|---|---|
| 2 years (2022-09-02) | 183.63% |
| 3 years (2021-09-03) | 144.00% |
| 5 years (2019-09-04) | 315.49% |
Valuing Pro Medicus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Pro Medicus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Pro Medicus's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 193x. In other words, Pro Medicus shares trade at around 193x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Pro Medicus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $113.1 million (£58 million).
The EBITDA is a measure of a Pro Medicus's overall financial performance and is widely used to measure stock profitability.
| Revenue TTM | $161.5 million |
|---|---|
| Operating margin TTM | 73.07% |
| Gross profit TTM | $126.8 million |
| Return on assets TTM | 30.68% |
| Return on equity TTM | 50.72% |
| Profit margin | 51.27% |
| Book value | 1.798 |
| Market capitalisation | $15.7 billion |
TTM: trailing 12 months
Dividend payout ratio: 1.65% of net profits
Recently Pro Medicus has paid out, on average, around 1.65% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.29% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Pro Medicus shareholders could enjoy a 0.29% return on their shares, in the form of dividend payments. In Pro Medicus's case, that would currently equate to about A$0.4 per share.
While Pro Medicus's payout ratio might seem low, this can signify that Pro Medicus is investing more in its future growth.
The latest dividend was paid out to all shareholders who bought their shares by 3 September 2024 (the "ex-dividend date").
Over the last 12 months, Pro Medicus's shares have ranged in value from as little as $70.5453 up to $151.84. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Pro Medicus's is 0.48. This would suggest that Pro Medicus's shares are less volatile than average (for this exchange).
Pro Medicus Limited, a healthcare informatics company, engages in the development and supply of healthcare imaging software, and radiology information (RIS) system software and services to hospitals, imaging centers, and health care groups in Australia, North America, and Europe. The company offers Visage RIS Visage 7 Enterprise Imaging Platform, a healthcare imaging software that provides radiologists, physicians, and clinicians with access and visualization capability for viewing 2-D, 3-D, and 4-D medical images; and picture archive and communication system (PACS)/digital imaging software. It also provides Visage RIS, a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; Promedicus.net, an e-health platform for secure email and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company was incorporated in 1983 and is headquartered in Richmond, Australia.
The best day trading platforms in Australia offer low fees and are packed full of features essential for algorithmic trading.
CHESS sponsorship allows you to directly own ASX listed shares in your own name, but it comes with some drawbacks. Find out if it's right for you.
Find out the different ways you can invest in the S&P 500 index from Australia.
Index funds are a hot topic right now, but how do you actually invest in them?
If you’re thinking of investing in gold, our guide will explain how and where to buy gold in Australia as well as the pros and cons of investing in it.
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
Looking to build your wealth? A guide on the investment accounts available in Australia.
Compare share trading apps to find out which app has all the tools and resources you need to reach your investment goals.
Learn how to find the cheapest brokerage fees and a range of flexible trading features when you buy and sell US shares.
Follow these tips to find the best share trading platform for you.